Atlas Trials

Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants

Clinical trial NCT03568435 · COMPLETED

Trial details

NCT number
NCT03568435
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney CancerRenal Cancer
Start date
2018-02-14
Primary completion
2020-12-21
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.